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TB PULMONARI DAN MEROKOK: FAKTOR-FAKTOR PENYUMBANG 
KEPADA KEMATIAN DI TERENGGANU DARI 2012 HINGGA 2016 
Latar belakang: Tuberculosis (TB) adalah antara masalah utama di dalam sektor 
kesihatan awam. Kadar insiden kes TB telah menurun dengan kadar yang perlahan 
secara global. Namun, di Terengganu, kadar insiden kes TB telah meningkat dari tahun 
2009 hingga ke tahun 2012 dan tidak menunjukkan penurunan sehingga tahun 2016. 
Di Malaysia, bilangan perokok telah menurun berdasarkan Kajian Morbiditi dan 
Kesihatan Kebangsaan 2006 dan 2011. Namun, masih kurang kajian yang telah 
dilakukan untuk mengkaji faktor-faktor kematian perokok dalam2w kalangan pesakit 
TB pulmonari. 
Objektif: Kajian ini bertujuan untuk mengenalpasti kadar kematian dan faktor-faktor 
yang berkaitan dengan kematian dalam kalangan perokok dan pesakit TB pulmonari 
di Terengganu dalam tahun 2012 hingga 2016. 
Metodologi: Kajian kes kontrol ini telah dijalankan pada bulan April 2018 dengan 
menggunakan data sekunder dari Sistem Maklumat TB (MyTB) dan dari borang 
TBIS10A1. Peratusan kematian pesakit TB pulmonari yang merokok dikira 
berdasarkan data yang diperoleh dari Sistem MyTB secara menyeluruh. Persampelan 
secara rawak menggunakan komputer telah digunakan untuk mendapatkan 185 kes 
dan 740 kontrol dari bilangan tersebut. Kes adalah pesakit TB pulmonari yang 
merokok yang telah meninggal semasa menjalani rawatan TB. Kontrol adalah pesakit 
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TB pulmonari yang telah sembuh atau sempurna rawatan. Analisa deskriptif, regresi 
logisitic mudah dan berganda digunakan untuk menganalisa data menggunakan SPSS 
versi 24. 
Keputusan: Kadar kematian pesakit TB pulmonari yang merokok adalah antara 14.8% 
dan 23.4%. Daripada 925 kes, purata umur pesakit adalah 48.6 tahun bagi kes dan 45.8 
tahun bagi kontrol. Majoriti pesakit adalah lelaki, berketurunan Melayu, tinggal di luar 
bandar, mempunyai tahap pendidikan pada Tingkatan 4 dan ke atas, tidak mempunyai 
pendapatan bulanan yang tetap, tidak mempunyai penyakit diabetes, mendapat 
imunisasi BCG, dikesan secara pasif, didiagnosa sebagai TB pulmonari sapuan kahak 
positif dan adalah kes baru TB. Hampir separuh bilangan kes adalah HIV positif dan 
majoriti daripada kontrol adalah HIV negatif. Lebih separuh bilangan kes mempunyai 
keputusan x-ray dada yang separa teruk manakala lebih separuh kontrol mempunyai 
keputusan minimal. Usia (aOR=1.04; 95% CI: 1.03, 1.05; p<0.001) dan HIV positif 
(aOR=9.51; 95% CI: 6.08, 14.88; p<0.001) adalah faktor yang menyumbang kepada 
kematian TB pulmonari yang merokok. Manakala, penghidap diabetes (aOR=0.58; 
95% CI:0.35, 0.94; p=0.028) dan yang berpendapatan lebih RM 940 (aOR=0.38; 95% 
CI: 0.20, 0.73; p=0.003) mempunyai kebarangkalian yang lebih rendah untuk 
kematian. 
Kesimpulan: Kadar peratusan perokok dalam kalangan pesakit TB pulmonari 
menurun dalam kadar yang perlahan dari tahun 2012 hingga tahun 2016. Pesakit yang 
mempunyai faktor yang menyumbang kepada kematian tinggi pesakit TB pulmonari 
yang merokok perlu diberi perhatian di dalam program kawalan TB kebangsaan bagi 
mengurangkan kadar kematian. 
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KATA KUNCI: tuberkulosis, kematian, merokok, umur, diabetis melitus, HIV 






PULMONARY TUBERCULOSIS AND TOBACCO SMOKING: FACTORS 
ASSOCIATED WITH ITS MORTALITY IN TERENGGANU FROM 2012 
UNTIL 2016 
Background: Tuberculosis (TB) is a major public health problem. The incidence of 
TB cases is reducing at a slower rate than expected as well as the TB death rate 
worldwide. However, the incidence of TB cases in Terengganu had increased from the 
year of 2009 until 2012 and had been fluctuating until 2016. The number of tobacco 
smoker in Malaysia had reduced accordingly. Little studies have been done to analyse 
tobacco smoker with pulmonary tuberculosis (PTB) patients as the subjects to 
determine the factors for its mortality. 
Objective: The aim of this study was to determine the proportion of mortality and the 
associated factor with mortality among PTB patients who smoke tobacco in 
Terengganu from 2012 until 2016. 
Methodology: A case-control study was conducted in April 2018 using a secondary 
data from MyTB System and from TBIS10A1 forms. The proportion of mortality 
among PTB and tobacco smoker were calculated based on the data extracted from 
MyTB System with no sampling method applied. Simple random sampling using a 
computer software was applied to select 185 cases and 740 controls. A case is the PTB 
patient who smokes tobacco smoking who had died during the TB treatment. A control 
is the PTB patient who smokes tobacco and was cured or completed TB treatment. 
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Descriptive analysis, simple and multiple logistic regression were used for analysis 
using SPSS version 24.  
Result: The proportion of mortality among PTB and tobacco smoking patients were 
between 14.8% and 23.4%. From the 925 selected respondents, the mean age for the 
case was 48.6 years (14.87) and the mean age for control was 45.8 years (15.32). 
Majority of the respondents are male, Malays, from a rural area, have the educational 
status of Form 4 and above, had no fixed monthly income, non-diabetic, received BCG 
immunisation, detected passively, diagnosed as PTB smear positive and were new 
cases. Almost half of the cases were HIV positive and the majority of the controls were 
HIV negative. More than half of the cases had chest x-ray results of moderately 
advanced while more than half of the controls had chest x-rays results of minimal. Age 
(aOR=1.04; 95% CI: 1.03, 1.05; p<0.001) and HIV positive (aOR=9.51; 95% CI: 6.08, 
14.88; p<0.001) were the factors contributing to mortality among PTB and tobacco 
smoking patients. Meanwhile, diabetic patient (aOR=0.58; 95% CI: 0.35, 0.94; 
p=0.028) and having monthly income of more than RM 930 (aOR=0.38; 95% CI: 0.20, 
0.73; p=0.003) had less risk for mortality. 
Conclusion: The proportion of mortality among PTB patients who smoke tobacco is 
reducing slowly from 2012 until 2016. Factors associated with mortality among PTB 
patients who smoke tobacco should be focus more in the national TB control 
programme in order to reduce the mortality risk.  




CHAPTER 1  
INTRODUCTION 
1.1 Background 
Tuberculosis (TB) is an infectious disease that is caused by Mycobacterium 
tuberculosis. It remains as one of the public health issue globally. A patient is 
considered as a TB patient once the laboratory investigations showed bacteriologically 
confirmed for TB or is diagnosed as a TB patient by a physician (World Health 
Organization, 2004). Commonly, a patient who has active TB disease will present with 
symptoms of having prolonged cough more than two weeks, haemoptysis, and any 
chest symptoms such as chest pain and shortness of breath (World Health 
Organization, 2011). TB may infect any organs in the body but mostly will infect the 
lung resulting in pulmonary TB (PTB) (World Health Organization, 2018). 
Once diagnosed with TB, the patient will have to undergo treatment under Directly 
Observed Treatment, Short-course (DOTS) strategy. DOTS strategy was introduced 
by Dr Karel Styblo for TB patients in Tanzania. In fact, a lot of patients had been 
benefited from the strategy all around the world after it was introduced in the 1970s. 
Using the five key components of DOTS strategy, the cure rate for TB patients has 
improved and increased. Other than that, the success of DOTS strategy has reduced 




In the 1990s, there has been a rising of TB cases worldwide. In the countries located 
in European Region and Regions of the Americas, the transmission of TB in the middle 
and high-income countries has been due to the increased immigration activity 
throughout the world. The high prevalence of Human Immunodeficiency Virus (HIV) 
cases in low developing countries contributes to the transmission of TB cases among 
the population. TB and smoking have also been responsible for the increase 
transmission of TB infection to other people on the population confounded by poverty, 
overcrowding and alcohol usage, causing a high incidence of TB cases world widely 
(van Zyl Smit et al., 2010). This increases the risk for TB mortality among the 
population. 
The increasing trend of TB cases in the 1990s has prompted for an effective control 
programme. In order to reduce the number of TB incidence in the world, Stop TB 
Strategy has been introduced in 1995. Stop TB Strategy has set a goal of detecting at 
least 70% of a patient diagnosed with PTB smear positive by 2005 to then reduce the 
number of TB cases by 50% compared to the number of TB cases by 1995 (World 
Health Organization, 2006).  
Thus, the world had achieved the target of Millennium Development Goal (MDG) 6 
which is to combat HIV and Acquired Immunodeficiency Syndrome, malaria and other 
diseases. The number of TB cases has reduced by years since 2014 after the 
introduction of expanded DOTS strategy but it reduces slower than targeted (World 
Health Organization, 2014b). In 2016, there are still about 10.4 million people were 
diagnosed with TB. TB has also been one of the top 10 causes of death worldwide. 
The reclining of TB incidence each year is only by two percent each year while the 
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aim of reducing the rate that we aim is about four to five percents for each year (World 
Health Organization, 2017b). 
With the introduction of Sustainable Development Goal (SDG) in 2015 following 
MDG, the number of TB incidence has been monitored periodically. The progression 
of the achievements has been reported for people to know that the action is been 
ongoing and will be continuously aiming to control TB infection (United Nation, 
2017). Each of the countries will have to report back to the United Nation regarding 
the achievement of infectious disease control mainly of TB and HIV infection.  
Hence, to ensure that the control of TB infection has been continuing aggressively to 
stop the transmission of TB in the world, SDG has set a target of reduced number of 
TB death by 90% in 2030. In 2015, “The End TB Strategy” has been introduced which 
aim to further reduce the number of TB death by 95% in 2035 (World Health 
Organization, 2015). 
1.2 Global TB burden 
Since United Nation has set a goal of reduction for TB cases globally to be 
achieved via MDG in 2015, the incidence of TB cases has decreased from estimated 
13.7 million people to 10.6 million people in 2016 (World Health Organization, 2009; 
World Health Organization, 2017a). The TB infection has spread to almost all around 
the world. The World Health Organization (WHO) African Region are affected the 
most by the diseases with an estimated incidence rate of 343 per 100 000 population 
in 2005 (Dye and Borgdorff, 2008).  
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Before 2005, the incidence rate of TB cases in the African Region has been increased 
due to the increasing number of HIV infected people living in the countries. TB 
infection is easily spread through people who have low immunity due to HIV infection 
giving rise to the prevalence of TB cases in the region. As TB has been considered as 
one of the major public health issues that should be controlled, improvements to the 
screening method and case detection have been conducted, thus giving rise to the 
number of incidence cases, especially in the African Region. As well as in African 
region, before 2005, there is also increasing trend of TB cases in Eastern Europe region 
(Dye and Borgdorff, 2008). This may be due to increasing immigration activity of 
people coming from high TB burden disease (World Health Organization, 2017a). 
However, in 2016, there has been a shift of trend in TB cases worldwide. 
Predominantly, WHO South-East Asia region has the highest number of incident cases 
followed by WHO African region, WHO Western Pacific Region, WHO Eastern 
Mediterranean Region, WHO European Region and WHO Region of the Americas. 
Globally, the average rate of declining was 1.4% with WHO European Region has the 
fastest rate of declining number of TB cases (World Health Organization, 2017a). 
A similar trend has also been described by Murray et al. (2014). The incidence for TB 
cases has been constantly increasing before 2005 and then started to reduce slowly 
until 2013. The prevalence of TB cases has been reducing since the year of 2000 until 
2013. The trend portrayed that the target that is set by the Stop TB Strategy was 
achieved even though it is in a slower rate than expected (World Health Organization, 
2006). Since TB has been recognized as one of the major public health issues, the 
control programme has been constantly aimed at reducing the mortality as to in-line 
with the MDG and now with SDG (World Health Organization, 2017b). Murray et al. 
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(2014) also described that the African Region and Southern Asia has the highest 
incidence and prevalence of TB cases compared to other regions.  
1.3 TB burden in Malaysia 
Malaysia is one of the countries situated in South-East Asia. In 1958, Malaysia 
which previously known as Malaya has joined the WHO Western Pacific Region. 
Since joining the WHO, Malaysia has actively improved its health services in order to 
achieve the target set by WHO such as MDGs and now towards achieving the target 
that already being outlined by SDG. 
Despite the reducing in the trend of TB cases portrayed by the WHO Western Pacific 
Region, the number of TB cases in Malaysia has been increasing gradually since the 
year 2004 (Terengganu State Health Department, 2018). During this year, Ministry of 
Health (MOH), Malaysia has intensified active case finding in order to detect all 
possible TB cases in our country, so that we can treat them earlier before they get any 
complications from the disease. 
In 2014, there is around 24,711 number of new cases diagnosed with TB (Ministry of 
Health Malaysia, 2015b). In 2015, TB remains the highest mortality rate among all the 
communicable diseases occurred (Ministry of Health Malaysia, 2016). The annual 
death rate for TB has been reducing from 1990 until 2013 with the latest reducing rate 




Murray et al. (2014) also described that Malaysia has the moderate burden of TB 
disease where the incidence of TB cases is 65 to 116 cases per 100,000 population. 
Meanwhile, the death rate for TB cases was also high in South Africa countries and 
some countries in Asia. Malaysia is grouped as a country with moderate TB death rate 
which is 6.9 to 18 death per 100,000 population (Murray et al., 2014). 
1.4 TB burden in Terengganu 
Terengganu is one of the states situated in East coast area of Peninsular 
Malaysia. It covers around 12,959 kilometres square, bounded by Kelantan in north 
and northwest, Pahang in the south and South China Sea in the east. The number of 
population in Terengganu is approximately 1.18 million people in 2016 (Department 
of Statistics Malaysia, 2018b). 
The number of all TB cases in Terengganu has been increasing from 2004 until 2009. 
However, since 2009 until now, the number of all TB cases has been fluctuating. The 
average number of all TB cases was 720 patients per year. The same goes for the 
number of PTB smear positive in Terengganu, the number of patients fluctuates since 
2008 until now (Terengganu State Health Department, 2016). 
In 2013, Terengganu has the second highest death rate of TB patients in Peninsular 
Malaysia after Perlis (Ministry of Health Malaysia, 2013; Ministry of Health Malaysia, 
2014; Ministry of Health Malaysia, 2015b; Ministry of Health Malaysia, 2016; 
Ministry of Health Malaysia, 2017) even though Terengganu is not the state with the 
highest TB incidence compared to Sabah, Labuan and Kuala Lumpur. The death rate 
for Terengganu in 2013 was 7.01 per 100,000 population following after Perlis with 
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8.29 per 100,000 population. From 2012 until now, the death rate of TB cases in 
Terengganu has been fluctuating almost with the similar trend with its incidence of TB 
cases. 
1.5 Smoking and Tuberculosis 
Previously, the relationship between tobacco smoking and TB was not clearly 
known. A lot of studies has been conducted to see the effect of tobacco smoking on 
TB infection since then. One study reported that tobacco smoking reduces the 
immunological response of the body to prevent TB infection. At the same time, 
tobacco smoking may also disrupt the ciliary function of the lung tissue, thus these 
resulting in high risk for people who smoke tobacco to have TB infection (van Zyl 
Smit et al., 2010).  
Tobacco smoking has been highly associated with TB infection (Slama et al., 2007; 
van Zyl Smit et al., 2010). About 0.8 million of TB cases has been contributed by 
tobacco smoking worldwide (World Health Organization, 2017a). There is a reduction 
in a number of tobacco smoker in the Malaysian population. The prevalence for current 
tobacco smoker based on Global Adult Tobacco Survey 2011 is 23.1% while the 
prevalence found in National Health and Morbidity Survey 2015 is 22.8% (Ministry 
of Health Malaysia, 2015c; World Health Organization, 2012). The prevalence of TB 
patient who ever smoked is higher compared to non-smoker group with 54.22% 
(Awaisu et al., 2010). Based on 13 studies done, the risk of getting TB disease for 
tobacco smoker is 2.33 (adjusted for age and sex) (Bates et al., 2007). 
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It was estimated that there will be 101 million deaths due to TB occurred by 2050 if 
nothing has been done to reduce the prevalence of smoking. The model also suggests 
that there will be a delay of 35 years in order to achieve the SDG target (Basu et al., 
2011). Tobacco smoking is associated with prolonging the duration of treatment with 
an adjusted odd ratio (aOR) of 2.43 (95% CI 1.18 to 5.03) (Atif et al., 2014a). Tobacco 
smoking reduces the rate of successful treatment in a TB patient even after controlling 
the other factors such as baseline characteristics, comorbidities, the extent of lung 
disease, lung cavitation and bacteriology (Leung et al., 2004). 
1.6 Rationale of the study 
 The number of tobacco smoker is decreasing in Malaysia but the prevalence of 
PTB patients who smoke tobacco simultaneously is increasing in our population and 
showed no sign of reducing (Ministry of Health Malaysia, 2013; Ministry of Health 
Malaysia, 2014; Ministry of Health Malaysia, 2015b; Ministry of Health Malaysia, 
2016; Ministry of Health Malaysia, 2017). Therefore, there is a need to study for the 
PTB patient who smokes tobacco as the subject. However, no study was found to 
determine mortality rate in and the risk factor for mortality among PTB patients who 
smokes tobacco, especially in Terengganu.  
Even though limited study had been conducted in determining the prevalence of 
tobacco smoker among PTB patients especially in Malaysia, none of the studies had 
focused on the trend of PTB patients who smoke tobacco over a duration of time (Atif 
et al., 2014b; Liew et al., 2015). Analysing the trend of prevalence for PTB patients 
who smoke tobacco is important because it reflects the current intervention plan that 
was done for them to encourage and help them to quit smoking. Therefore, we can 
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review back and revise a new strategy to deliver health education for them. It also 
helps the government to focus more on the specific group when delivering the 
messages. 
Since 2014, MOH Malaysia had started to strengthen assessing tobacco smokers 
among TB patients when they come for DOTS every day for anti-TB treatment. 
Ideally, we would want to intervene with all smokers who had been diagnosed with 
TB and encourage to change their lifestyle to no smoking. This is in conjunction with 
a number of studies that had mentioned how smoking affected treatment outcome and 
may increase the risk for mortality among TB patients (Bates et al., 2007). However, 
because of the high number of TB patients attended the session, the healthcare provider 
may want to focus more on patients with specific factors which may contribute more 
to poor treatment outcome. Thus, targeting this group of patients may increase the 
chance for successful treatment, thus reducing the mortality rate among TB patients 
much higher and much faster according to the target set by SDG (United Nation, 2017).   
1.7 Research Questions 
We have been asking two questions regarding tobacco smoking behaviour, TB 
patients and mortality.  
i. What is the proportion of mortality among PTB patients who smokes tobacco 
in Terengganu between the years 2012 and 2016?  
ii. What are the associated factors for mortality among PTB patients who smokes 




As the first research question is regarding the prevalence of mortality among 
PTB patients who smoke tobacco in Terengganu, no hypothesis can be deducted for 
the questions. For the second research objective, the hypothesis is age, gender, 
ethnicity, place of living, diabetes mellitus (DM) status, HIV status, immunisation 
status, category of TB and type of PTB smear are associated with mortality among 
PTB patients who smokes tobacco in Terengganu between 2012 and 2016. 
1.9 Objectives 
1.9.1. General objective 
The general objective of this study was to determine the mortality rate and 
factors associated with mortality among PTB patients who smokes tobacco in 
Terengganu between 2012 and 2016. 
1.9.2 Specific objectives 
There were two specific objectives for this study answering both the research 
questions that has been asked previously.  
i. To determine the proportion of mortality among PTB patients who smoke 
tobacco in Terengganu between 2012 and 2016. 
ii. To determine the risk factors associated with mortality among PTB patients 
who smoke tobacco in Terengganu between 2012 and 2016. 
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CHAPTER 2  
LITERATURE REVIEW 
2.1 The proportion of PTB patients who smoke tobacco 
 The reported proportion of overall tobacco smoker among TB patients which 
included current smoker and ex-smoker in Kuala Lumpur Federal Territory and 
Penang was 54.2% in 2010 (Awaisu et al., 2010). More specific report regarding the 
proportion of TB and tobacco smoking among patients treated in Hospital Pulau 
Pinang, Hospital Universiti Sains Malaysia and University Malaya Medical Centre 
was 39.0% (Syed Suleiman et al., 2012). Furthermore, Atif et al. (2014a) reported that 
52.1% of TB patients were tobacco smoker in Hospital Pulau Pinang. These reports 
highlighted the high proportion of TB and tobacco smoking patients in Malaysian 
population.  
The high prevalence of PTB patients who smoke tobacco could be due to the high 
number of male TB patients in the population. Based on National Health and Morbidity 
Survey 2015, 43.0% of current smoker were among male while only 1.4% of female 
population were smoker (Ministry of Health, 2015). Therefore, with the majority of 
male patients were diagnosed with TB, we would expect that the prevalence of tobacco 
smoker will be high. 
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2.2 The proportion of mortality among tobacco smoker and TB 
 Few studies and reports claimed a closed relationship between TB patients who 
smokes tobacco and mortality rate. The current report claimed the mortality rate in TB 
patient who smokes was 11.8% in 2015 in Malaysia (Liew et al., 2015). The mortality 
rate of tobacco smoker and diagnosed with TB in Iran was slightly high as compared 
to Malaysia which was 16.8% (Alavi-Naini et al., 2013). A different study highlighted 
the lower tendency for favourable outcome among PTB patients who smoke tobacco 
with an odd ratio of 0.8 (95% CI: 0.36, 1.79) (Dujaili et al., 2015).  
Atif et al. (2014b) had reported that smoking is highly associated with poor treatment 
outcome for TB due to its impact on the overall quality of life after diagnosed with TB 
disease. Smoking had been described to be able to reduce patient’s immunity thus 
resulting in an unfavourable outcome. Furthermore, smoker, especially among male 
TB patients was more likely to be non-compliance with TB medication, therefore, will 
more likely be resulting in TB death among tobacco smokers (Lavigne et al., 2006). 
2.3 Associated factors for TB mortality 
 As for the associated factors of TB mortality, limited study had been found to 
report on the associated factors for mortality among PTB patients who smoke tobacco. 
In contrast with that, a lot of other studies had been conducted to determine the factors 
associated with TB mortality comparing between tobacco smoker and non-tobacco 
smoker. Few studies had actually reported the associated factors for mortality among 




However, Lin et al. (2014) only reported the association of age and gender with TB-
related mortality and non-TB-related mortality while Reed et al. (2013) only determine 
the association between the number of cigarettes smoked per day among diabetic 
smoker who died and alive. No other study was found to determine the association of 
different factors with mortality among PTB patients who smoke tobacco. 
2.3.1 Age 
Older age was considered a factor for increased mortality among TB patients 
with concurrent DM. A study in Taiwan reported the mean age for mortality related to 
TB disease was 75 years old (Lin et al., 2014). Furthermore, Syed Suleiman et al. 
(2012) had described that elderly with TB and DM had a greater risk for mortality with 
an aOR of 12.3 compared to a patient with TB or DM alone. For each increasing of 1 
year of age, the risk for mortality is 1.03 (95% CI: 1.01, 1,06; p=0.036) (Atif et al., 
2014a).  
2.3.2 Gender 
 Both studies in Malaysia and in Penang showed that male TB patients had a 
higher risk of mortality compared to female. The crude odd ratio for TB mortality 
among male was 1.68 and the aOR was 1.22 as described by Liew et al. (2015). 
Another study claimed gender was not significantly associated with mortality as the 
aOR for TB mortality among male in Penang was 1.79 (95% CI: 0.64, 4.98; p=0.268) 
but was significantly associated with unfavourable outcomes (aOR=2.15, 95% CI: 
1.20, 3.87; p=0.10) (Atif et al., 2014a). In South Korean, male was also found to be 
significantly higher hazard ratio compare to female with hazard ratio of 1.58 (95% CI: 
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1.27, 1.97) in male and hazard ratio of 1.55 (95% CI: 1.00, 2.41) in female after 
adjusting to age and age-squared (Jee et al., 2009). Liew et al. (2015) had described 
that the reason why male had higher mortality rate compared to female was because 
of the compliancy to anti-TB treatment was less in male compared to female. 
2.3.3 Ethnicity 
Ethnicity also played a role in determining the favourable or the unfavourable 
outcome in TB patients. Different ethnic was reported to have a significant relationship 
with TB mortality.  
Ismail and Bulgiba (2013b) carried out a study among TB patients in Institute of 
Respiratory Medicine, Malaysia and found that Malay has the higher risk of mortality 
with adjusted hazard ratio of 4.48 (95% CI: 1.73, 11.64; p=0.002) among TB/HIV 
patient compared to another ethnicity besides Chinese and Indian. Their findings in 
line with a study conducted by Liew et al. (2015) which showed non-Malay ethnicity 
(Chinese, Indigenous West Malaysia, Indigenous Sabah and others) were significantly 
less associated with mortality with the lower aOR for mortality ranged from 0.72 to 
0.97 (p-value ranging from <0.001 to 0.012). A similar study of determining the factors 
for unsuccessful outcome among patients with TB/HIV also reported the percentage 
of the population studied who have unsuccessful outcome are the highest among Malay 
and Indian patients (Ismail and Bulgiba, 2013a). 
This reflects back to the National TB Programme that has been established in 
Malaysia. Lower risk for mortality among indigenous people in Malaysia has been 
linked to the successful of TB programme in the area where a greater coverage for 
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DOTS has been seen among the indigenous TB patients. Furthermore, they have less 
co-morbidities compared to Malay people which reduces the risk of dying among the 
indigenous patient (Liew et al., 2015). 
However, based on a study reported by Dooley et al. (2009), there was no association 
between TB treatment outcome for death between the ethnicity of the Asian, Black or 
White population in 2005. Another study from United States of America reported that 
the risk for TB death was significantly higher among non-citizen population compared 
to United States citizen (Rodwell et al., 2008). 
2.3.4 Place of living 
There are very limited studies measured the relationship between an urban or 
rural area with TB mortality. In Malaysia, rural has higher risk of mortality with crude 
odd ratio of 1.26 (95% CI: 1.15, 1.38; p<0.001) and aOR of 1.25 (95% CI: 1.08, 1.44; 
p=0.002) (Liew et al., 2015). From a study reported in 2016, overcrowding area and a 
lower socioeconomic region that could be refer to the rural area were associated with 
increased incidence of TB cases (Krieger et al., 2016), thus may also lead to increased 
risk for mortality among the population. Contradict to Liew et al. (2015) and Krieger 
et al. (2016), Kliiman and Altraja (2009) reported that urban was significantly 
associated with poorer TB treatment outcome among multi-drug resistance and 
extensive-drug resistance among Estonia population. This could be due to a lot of other 
factors such as work that may interfere with the accessibility for the patient to take 
their TB medication as required. 
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2.3.5 Diabetes Mellitus 
Many studies found TB patient with DM as their co-morbid had a higher risk 
of mortality. A recent study that was conducted in patient who has TB and DM showed 
high mortality rate as compared to patient with TB alone with the crude odd ratio of 
1.34 (95% CI: 1.19, 1.50; p<0.001) but the aOR was 1.02 (95% CI: 0.85, 1.19; 
p=0.942) (Liew et al., 2015). Another published study in 2014 reported that DM was 
not significantly associated with mortality (aOR=2.02, 95% CI: 0.97, 4.18; p=0.060) 
but was significantly associated with prolonged TB treatment (aOR=6.80, 95% CI: 
2.98, 15.51, p<0.001) in Penang (Atif et al., 2014a). Reed et al. (2013) reported based 
on a study conducted in the Republic of Korea that the adjusted hazard ratio for 
TB/DM patient who smoked more than one pack per day was 4.25 (95% CI: 1.06, 
17.08; p=0.004). 
Patient with DM is said to be more compliance to anti-TB treatment especially when 
they had been compliance with the diabetic treatment that they had been receiving 
before the diagnosis of TB, thus diabetic patient were more adhered to medication and 
reduces the risk for mortality (Liew et al., 2015). However, Atif et al. (2014a) reported 
that due to the effect of diabetes to the immune system of TB patients, patient will 
more likely to have prolonged TB treatment compared to non-diabetic patient. 
2.3.6 HIV status 
HIV is already known to weaken immune status and worsened the disease 
progression in TB patient. It was reported as significantly associated with mortality 
among TB patients in Malaysia with the aOR for mortality of patient with TB and HIV 
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co-infection was 8.76 (95% CI: 7.24, 10.58; p<0.001) (Liew et al., 2015). However, 
in San Francisco, Nahid et al. (2011) reported the adjusted hazard ratio for TB and 
HIV co-infection patient was 2.57 (95% CI: 1.17, 5.64; p=0.02), much less as 
compared to Malaysia. A similar finding was reported based on a study in Estonia 
where TB patient with HIV positive has higher mortality rate compared to HIV 
negative patient (aOR=10.16, 95% CI: 1.17, 88.84; p=0.04) (Kliiman and Altraja, 
2009). 
2.3.7 BCG immunisation status 
All new born babies are given Bacillus Calmette–Guérin (BCG) vaccination 
globally including in Malaysia. The role of immunisation for TB has been questionable 
nowadays. However, patient without BCG scar had been reported to have higher risk 
for TB mortality with crude odd ratio of 1.14 (95% CI: 1.02, 1.26; p=0.016) and the 
aOR of 1.13 (95% CI: 0.94, 1.35; p=0.185) (Liew et al., 2015). Aaby et al. (2011) 
reported based on a study in six districts in Guinea Bassau, the mortality rate for infant 
received BCG vaccination was not significantly reduced, but the actual number of 
mortality was reduced as the BCG vaccination may help to boost infant’s immunity 
throughout neonatal period. Based on a systematic review done by Mangtani et al. 
(2013), BCG vaccination given after birth has significant protection against TB disease 




2.3.8 Category of TB: New/Retreatment 
Each time patient is diagnosed with TB, he or she will be categorized 
accordingly whether the patient is a new case of TB or a retreated patient. In Malaysia, 
a patient who had TB previously had a higher risk for mortality with a crude odd ratio 
of 1.48 (95% CI: 1.26, 1.74; p<0.001) but with the aOR of 1.02 (95% CI: 0.81, 1.30; 
p=0.850) (Liew et al., 2015). This result is similar with a study done in Iran where a 
patient who had TB previously had the higher tendency for mortality compared to a 
patient who was newly diagnosed with TB with an aOR of 6.8 (95% CI: 2.22, 21.3; 
p=0.017) (Alavi-Naini et al., 2013). This could be due to the fact that the patient had 
been given treatment before and was more likely to develop drug resistance to anti-TB 
treatment, thus may lead to unfavourable treatment outcome among TB patients 
(Kliiman and Altraja, 2009). 
However, a study done in Hong Kong found that the risk for mortality was higher in 
newly diagnosed patient compared to retreatment TB patient with odd ratio of 2.61 
(95% CI: 1.80, 3.80; p<0.001) in newly diagnosed TB patient compared to 2.48 (95% 
CI: 1.04, 5.89; p=0.04) in retreated TB patient (Leung et al., 2004). 
2.3.9 Type of PTB smear: Positive/Negative 
PTB patient can be diagnosed with PTB smear positive or PTB smear negative. 
A different type of smear was reported to have different impact on mortality rate. A 
study conducted in Malaysia showed PTB smear positive patients were higher risk for 
mortality with a crude odd ratio of 1.33 (95% CI: 1.20, 1.47; p<0.001) as compared to 
those smear negative (Liew et al., 2015). In South Africa, TB/HIV patient with sputum 
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smear positive noted to have less risk for mortality with a crude hazard ratio of 0.73 
(95% CI: 0.63, 0.84; p<0.001) (Pepper et al., 2015). Meanwhile, contradicts with the 
previous study, a study conducted in Iran reported TB patient with sputum smear 
positive showed the much higher risk of mortality with an aOR of 13.4 (95% CI: 6.8, 
33.6; p=0.002) (Alavi-Naini et al., 2013). 
2.4 Conceptual framework 
 Figure 2.1 illustrates factors that may associate with mortality as one of the 
treatment outcomes for PTB patients who smoke tobacco. The highlighted factors are 
written in bold and marked with asterisk (*) were not included in this study. All PTB 
patients who are tobacco smoker will be marked with smoking status as “Yes”. Along 
the course of completing the treatment for TB, age, gender, ethnicity, place of living, 
educational status, monthly income, marital status, DM status, HIV status, number of 
presenting symptoms, sputum AFB reading, chest x-ray, MDR-TB status, case 
detection, case category, type of PTB, immunisation status, places of treatment and 
whether DOTS was been given by a healthcare provider are associated with the success 
of the treatment or can also interpret as a lot of factors might be contributed to the 






Figure 2.1: The conceptual framework explaining the factors associated with mortality among PTB patients who smoke tobacco
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CHAPTER 3  
METHODOLOGY 
3.1 Research design 
For objective 1, a retrospective cohort study was conducted to determine the 
prevalence of PTB patients who smokes tobacco died in Terengganu from the year 
2012 to 2016. A case-control study was conducted in order to answer the second 
objective. 
3.2 The study area, time & duration 
The study area was in Terengganu which is one of the states in Malaysia. It is 
situated in East coast area of Peninsular Malaysia covering around 12,959 kilometres 
square. At its north, it is bounded by Kelantan and at its south, it is covered by Pahang. 
The South China Sea is located in the east. There are eight districts in Terengganu 
which are Kuala Terengganu as the capital city of Terengganu, Kuala Nerus, Marang, 
Hulu Terengganu, Besut, Setiu, Dungun and Kemaman. 
The number of population in Terengganu is approximately 1.18 million people in 2016 
increasing to 1.21 million people in 2017. The number of male population is higher 
compared to female which is 620,000 of male and 590,000 of female in 2017 
(Department of Statistics Malaysia, 2018b). In 2016, the crude death rate among 
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Terengganu population is 5.8 per 1,000 population (Department of Statistics Malaysia, 
2018c). 
About 60% of the Terengganu people aged below 30 years old with the age group of 
20 to 24 years old had the highest number of population in 2017. In terms of ethnicity, 
94.4% of its population are Malays. There are only 2.4% of the Chinese population in 
Terengganu, 0.2% Indians and 0.3% is other Malaysian ethnicity. Only 2.8% of the 
population in Terengganu is non-citizen (Department of Statistics Malaysia, 2018a). 
The duration of the study was between 8th of April 2018 after ethical approval for 
National Medical Research Register and Universiti Sains Malaysia Research Ethics 





Figure 3.1: Map showing the location of Terengganu in Peninsular Malaysia (smaller 
box on the upper right) and the districts in Terengganu 
 
3.3 Reference population 
The reference population for this study was patient who were diagnosed as 
PTB and smokes tobacco. Thus, the result of this study can be inferred to this reference 
population that present in Terengganu. 
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3.4 Source population 
The source population for this study was patients who were diagnosed as PTB 
patient and smokes tobacco registered in the TB Information System (TBIS) in 
Terengganu in 2012 until 2016. Those patients who were registered in TBIS from the 
year 2012 to 2016 were chosen in order to ensure patients had completed their course 
of TB treatment. Thus, the treatment outcome of all TB patients already completed 
and stated in the TBIS. 
3.5 Sampling frame 
For selection of a case, the cases were PTB patients who smoke tobacco, died 
and registered in Terengganu in the MyTB System in the year 2012 until 2016, fulfilled 
the inclusion criteria, and had already ruled out the exclusion criteria. 
For selection of a control, the controls were PTB patients who smoke tobacco 
registered in Terengganu in the MyTB System in the year 2012 until 2016, alive at the 
end of TB treatment, fulfilled the inclusion criteria, and had already ruled out the 
exclusion criteria. 
3.6 Data criteria 
For case, the inclusion criteria were patients registered as PTB and reported as 
tobacco smoker with the treatment outcome of died. The exclusion criterion for the 
case was being non-Malaysian. 
